论文部分内容阅读
涨升空间有所提升和盈利动能大幅提升是鱼跃医疗新入选I66的主要原因。最新综合目标价为99.43元,12个月涨升空间达到18.91%。公司龙头地位初显中国家纺行业尚处于成长期,
Rising space has improved and the substantial increase in profitability is the main reason for diving selected I66. The latest integrated target price of 99.43 yuan, 12 months rose space to 18.91%. The leading position of the company has shown that China’s textile industry is still in its growth stage.